Compugen Stock

Compugen Other Income/Expense

The Other Income/Expense (Net) of Compugen (CGEN) as of Aug 17, 2026 is 4.07 M USD. In the previous year, Other Income/Expense (Net) was 5.18 M USD — a change of -21.44% (lower).

Other Income/Expense

4.07 MUSD

YoY

-21.44%

Last updated:

Other Income/Expense (Net) of Compugen is 2026 4.07 M USD. Other Income/Expense (Net) of Compugen was 2025 5.18 M USD. It decreases by -21.44% lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Other Income/Expense (Net) of Compugen is 4.07 M USD in 2026.

Other Income/Expense (Net) of Compugen changed from 5.18 M USD to 4.07 M USD, representing a -21.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Other Income/Expense (Net) Compugen since 2006 – with annual values, charts, and detailed analysis.

Other income and expense includes non-operating items such as gains/losses on investments, foreign exchange, and other non-core activities.

Other Income/Expense (Net)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Other Income/Expense (Net)'s Compugen historically and in real time.

Access this data via the Eulerpool API

Income Statement — Compugen

All Key Metrics — Compugen